Compare Baidu Inc (BIDU) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baidu Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Baidu Inc trades at $104.68 (market cap $36.18B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.3× Baidu Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Baidu Inc pays none. Which is the better fit depends on your goals.
| BIDU | REGN | |
|---|---|---|
Market Cap | $36.18B | $82.06B |
Sector | Media | Health |
52-Week High | $162.52 | $812.27 |
52-Week Low | $86.76 | $555.51 |
Enterprise Value | $32.81B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baidu Inc
Baidu, Inc. operates an Internet search engine. The Company offers algorithmic search, enterprise search, news, MP3, and image searches, voice assistance, online storage, and navigation services. Baidu serves clients globally.
Read more on BIDU →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
